KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Liabilities and Shareholders Equity (2016 - 2026)

Pfizer has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $208.0 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity changed 0.01% to $208.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $831.3 billion through Mar 2026, down 3.01% year-over-year, with the annual reading at $208.2 billion for FY2025, 2.45% down from the prior year.
  • Liabilities and Shareholders Equity was $208.0 billion for Q1 2026 at Pfizer, roughly flat from $208.2 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $226.5 billion in Q4 2023 and troughed at $41.1 billion in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $208.2 billion (2025), against an average of $199.1 billion.
  • Year-over-year, Liabilities and Shareholders Equity fell 11.22% in 2022 and then surged 422.64% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $197.0 billion in 2022, then grew by 14.98% to $226.5 billion in 2023, then decreased by 5.79% to $213.4 billion in 2024, then dropped by 2.45% to $208.2 billion in 2025, then fell by 0.08% to $208.0 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Liabilities and Shareholders Equity are $208.0 billion (Q1 2026), $208.2 billion (Q4 2025), and $209.0 billion (Q3 2025).